It is thus likely that sPLA2-III mobilizes a pool of these pro-inflammatory and/or pro-tumorigenic lysophospholipids from DSS-damaged, rather than intact, epithelial membranes, thus contributing to the exacerbation of colonic inflammation and subsequent progression to colonic cancer. Here, PLA2G3 is linked to colonic neoplasm.